Clinical Review State of the Art Review Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management BMJ 2023; 380 doi: https://doi.org/10.1136/bmj-2021-069717 (Published 27 February 2023) Cite this as: BMJ 2023;380:e069717 Article Related content Metrics Responses Peer review Related articles Paper Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) Published: 25 January 1997; BMJ 314 doi:10.1136/bmj.314.7076.253 Clinical Review Advances in the management of systemic lupus erythematosus Published: 26 October 2023; BMJ 383 doi:10.1136/bmj-2022-073980 See more Advances in management of heart failure BMJ April 10, 2024, 385 e077025; DOI: https://doi.org/10.1136/bmj-2023-077025 Effectiveness and safety of drugs for obesity BMJ March 25, 2024, 384 e072686; DOI: https://doi.org/10.1136/bmj-2022-072686 Management of chronic pancreatitis BMJ February 26, 2024, 384 e070920; DOI: https://doi.org/10.1136/bmj-2023-070920 Advances in diagnosis and treatment of bladder cancer BMJ February 12, 2024, 384 e076743; DOI: https://doi.org/10.1136/bmj-2023-076743 New advances in type 1 diabetes BMJ January 26, 2024, 384 e075681; DOI: https://doi.org/10.1136/bmj-2023-075681 Cited by... A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndromeAbstract Fulltext PDF Advances in the management of systemic lupus erythematosusAbstract Fulltext PDF
